Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years. AMD affects the retinal pigment epithelium (RPE) and Bruch’s membrane in the macula, l...
Autors principals: | Borchert, GA, Shamsnajafabadi, H, Ng, BWJ, Xue, K, De Silva, SR, Downes, SM, MacLaren, RE, Cehajic-Kapetanovic, J |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Frontiers Media
2024
|
Ítems similars
-
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
per: Grace A. Borchert, et al.
Publicat: (2024-07-01) -
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
per: Grace A. Borchert, et al.
Publicat: (2023-08-01) -
Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
per: Michelle E. McClements, et al.
Publicat: (2020-11-01) -
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
per: Borchert, GA, et al.
Publicat: (2024) -
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy
per: Hoda Shamsnajafabadi, et al.
Publicat: (2023-08-01)